Malaria Treatment Market Share, Trends, Scope and Global Outlook
[Research Report] The malaria treatment market was valued at US$ 3,296.98 million in 2022 and is expected to reach US$ 24,487.73 million by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030.
Market Insights and Analyst View:
Malaria is a life-threatening infectious disease caused by the Plasmodium parasite. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing launch of advanced diagnostic tools and rising research activities to provide effective therapeutics are driving the growth of the malaria treatment market. Over the two peak years of the pandemic (2020–2021), COVID-related disruptions led to more than 13 million malaria cases and 63,000 associated deaths. The WHO African Region continues to hold a disproportionately huge share of the global malaria burden. In 2021, Africa was home to approximately 95% of all malaria cases and 96% of deaths. Furthermore, children under 5 years of age accounted for ~80% of all malaria deaths in the region. According to the same source, Nigeria, Democratic Republic of the Congo, the United Republic of Tanzania, and Niger accounted for over half of all malaria deaths worldwide.
Growth Drivers and Challenges:
Malaria, one of the acute febrile illnesses, is caused by plasmodium parasites and spreads through the infected female Anopheles mosquitoes. Five parasite species in humans mainly cause malaria, and two of these species—Plasmodium falciparum and P. vivax—are considered the greatest threat to human health. Also, P. falciparum is the deadliest malarial parasite, and it is most widely spread across the African continent. Further, P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). Thus, the rising prevalence of malaria in different regions across the globe boosts the malaria treatment market growth.
The occurrence of antimalarial drug resistance can be due to the growing availability and use of counterfeit drugs, overuse of certain medications for prevention, incomplete treatment of active infections, and the parasite's adaptability at the genetic and metabolic levels, among others. The elevated usage of counterfeit antimalarial drugs is a primary concern faced by healthcare sectors worldwide. Counterfeit antimalarial drugs are prominently used in most African countries due to high medical costs. People also opt for counterfeits to receive treatments at lower costs, while a few countries lack reasonable quality control and verification processes, which ease access to these counterfeit drugs. According to the Journal of Vector-Borne Diseases 2020, counterfeit antimalarial drugs not only resulted in an economic loss but also decreased the efficacy of treatment, thereby resulting in the loss of faith in the healthcare system and increasing the chances of drug resistance in the parasites.
Thus, the surging dominance of counterfeit antimalarial drugs is hindering the growth of the malaria treatment market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Malaria Treatment Market: Strategic Insights
Market Size Value in US$ 3,296.98 million in 2022 Market Size Value by US$ 24,487.73 million by 2030 Growth rate CAGR of 28.5% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Malaria Treatment Market: Strategic Insights
| Market Size Value in | US$ 3,296.98 million in 2022 |
| Market Size Value by | US$ 24,487.73 million by 2030 |
| Growth rate | CAGR of 28.5% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. In 2022, the vaccines segment held the largest share of the market. Also, the segment is expected to record the highest CAGR during the forecast period. Vaccines provide active acquired immunity against particular infectious diseases. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and an increasing pipeline of vaccine candidates. The only approved malaria vaccine is RTS,S vaccine developed by GlaxoSmithKline to prevent the Plasmodium falciparum malaria parasite from entering the liver. It requires four injections and is being provided to young children through national immunization programs in sub-Saharan African countries. The vaccine is being given as part of a pilot introduction that began in 2019. International and local cooperation has been integral in the development of the vaccine, and by the end of the pilot roll-out in 2024; funding for RTS,S is estimated to exceed US$ 1 billion, out of which US$ 700 million will be provided by GSK, which has donated 10 million doses for the pilot.
The malaria treatment market, by route of administration, is bifurcated into oral and parenteral. In 2022, the oral segment held a larger share of the market. However, the parenteral segment is anticipated to record a higher CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, noninvasiveness, least sterility constraints, cost-effectiveness, and flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs. The low manufacturing cost of tablets, capsules, and other orally administered drugs is also a key driving factor for the malaria treatment market growth. A few of the available anti-malarial drugs are quinine, quinidine, chloroquine, amodiaquine, tafenoquine proguanil, chlorproguanil, and artemisinin. The ACTs and the combination therapies are being used for the treatment of uncomplicated malaria caused by the P. falciparum parasite. ACTs are the most effective antimalarial medicines that are currently available in the market.
By distribution channel, the malaria treatment market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. In 2022, the direct tender segment held the largest share of the market. In addition, the same segment is also expected to record the highest CAGR during the forecast period. A tender is an offer to do specific duties or provide items for a fixed amount. In the first step of this tender procedure, contractors will be asked to submit sealed bids for construction or to offer particularly planned services or products within a specific time limit. The e-tendering procedure in India is designed to ensure that work for the government or a specific client is completed in a timely manner. A few places, for example, may have specific procurement regulations that dictate the way decisions are made and which tenders are accepted. For instance, the All India Institute of Medical Sciences, Managing Director, Bihar Medical Services and Infrastructure Corporation Limited (Government of Bihar), Patna (AIIMS Patna) invites bids from reputed, experienced, and financially established companies/firms/agencies for malaria testing kits and drugs for different healthcare facilities in India.
Regional Analysis:
Based on geography, the malaria treatment market is categorized into five key regions—North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. The Middle East & Africa held the largest share of the malaria treatment market in 2022. Rising disposable income, growing demand for targeted nutrition, and rising awareness regarding malaria treatment and supplements are a few of the prominent factors propelling the market growth.
The malaria treatment market in Nigeria holds the largest market share, and Saudi Arabia is the fastest-growing market during the forecast period. According to the Severe Malaria Observatory report, malaria is significantly prominent across Nigeria, and ~97% of the population is at a high risk of suffering from malaria. Further, according to the 2021 World Malaria Report, Nigeria recorded the highest number of malaria cases, with the highest number of deaths, i.e., ~32% of global malaria deaths were recorded in the country in 2020. To overcome such a high prevalence of malaria, Nigeria's collaboration with the National Malaria Elimination Program (NMEP) started the High Burden High Impact (HBHI) approach with technical support from the WHO.
Malaria Treatment Market Opportunity:
Growing Strategic Initiatives by Market Players
A few major players operating in the malaria treatment market are increasingly focusing on the adoption of various strategies such as product innovations, launches, and approvals; R&D investments; and mergers and acquisitions in order to remain competitive. A few of these initiatives are mentioned below:
- In March 2022, tafenoquine, a novel drug used to treat a specific strain of malaria, was licensed in Australia by Medicines for Malaria Venture (MMV), which codeveloped the drug with GlaxoSmithKline (GSK) for children and adolescents. The drug is combined with the widely used antimalarial drug—chloroquine.
- In December 2021, Zydus Cadila announced the plan to develop its antimalarial drug ZY19489 with Medicines for Malaria Venture, which received US FDA approval. According to the company, the Phase I trial of ZY19489 demonstrated a long half-life and the potential for a single-dose cure for malaria. In a separate malaria challenge trial, strong antimalarial activity was displayed after a single oral dose of ZY19489.
Therefore, the abovementioned strategic initiatives by the market players are expected to provide growth opportunities for the malaria treatment market in the coming years.
Malaria Treatment Market Report Scope
Competitive Landscape and Key Companies:
A few of the prominent players operating in the global malaria treatment market are Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, Emmaus Life Sciences Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, Lupin Ltd, and Teva Pharmaceutical Industries Ltd. These companies focus on the development of new technologies, advancements in existing products, and expansion of geographic footprint to meet the growing consumer demand worldwide and expand their product range in specialty portfolios. Companies operating in the global malaria treatment market are implementing various inorganic and organic strategies. A few of them are mentioned below:
- In November 2022, Novartis and Medicines for Malaria Venture (MMV) announced its decision to move to a Phase 3 study for a novel non-artemisinin combination to treat uncomplicated malaria. This novel combination also contains an optimized formulation of lumefantrine, which allows it to be given once daily instead of the usual twice-daily administration.
- In October 2021, GlaxoSmithKline (GSK) plc welcomed WHO recommendation for the broader deployment of GSK’s RTS,S malaria vaccine to reduce childhood illness and deaths from malaria in children (living in sub-Saharan Africa and other regions with moderate to high transmission). RTS,S is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce malaria in children. The vaccine is the result of over 30 years of research led by GSK, with PATH and other partners.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment, Route of Administration, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
increasing prevalence of malaria and government and private sector's initiative to raise awareness about malaria are the most significant factors responsible for the overall market growth.
Cipla Ltd, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Sanofi SA., GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, Lupin Ltd among others are among the leading companies operating in the malaria treatment market.
Malaria treatment market is segmented by countries comprising of North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
The direct tender segment dominated the malaria treatment market and accounted for the largest market share in 2022.
Based on route of administration, the oral segment took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.
Malaria is a serious infection spread by an infected mosquito. The infection is very common in certain parts of the world, such as large areas of Africa and Asia, Central and South America, and the Dominican Republic and Haiti. However, malaria is an entirely preventable and treatable disease if tackled at an early stage. For example, malaria is treated with a prescription drug to kill the parasite. The types of drugs and the length of treatment vary depending on the type of malarial parasite infection, the severity of symptoms, and age.
Malaria is a serious infection spread by an infected mosquito. The infection is very common in certain parts of the world, such as large areas of Africa and Asia, Central and South America, and the Dominican Republic and Haiti. However, malaria is an entirely preventable and treatable disease if tackled at an early stage. For example, malaria is treated with a prescription drug to kill the parasite. The types of drugs and the length of treatment vary depending on the type of malarial parasite infection, the severity of symptoms, and age.
The vaccines segment dominated the malaria treatment market and accounted for the largest market share in 2022.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights - Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Malaria Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis – Malaria Treatment
5. Malaria Treatment Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Prevalence of Malaria
5.1.2 Rising Initiatives to Raise Awareness about Malaria
5.2 Market Restraints
5.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Market Players
5.4 Future Trends
5.4.1 Extending Pipeline of New Drugs and Vaccines
5.5 Impact Analysis
6. Malaria Treatment Market - Global Market Analysis
6.1 Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030
7. Malaria Treatment Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 Vaccines
7.3.1 Overview
7.3.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Generic Drugs
7.4.1 Overview
7.4.2 Generic Drugs Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Originators
7.5.1 Overview
7.5.2 Originators Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. Malaria Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Malaria Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Direct Tender
9.3.1 Overview
9.3.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
9.5 Retail Pharmacies
9.5.1 Overview
9.5.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
9.6 Online Pharmacies
9.6.1 Overview
9.6.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others : Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Malaria Treatment Market - Geographical Analysis
10.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1 North America: Malaria Treatment Market, by Treatment
10.1.2.2 North America: Malaria Treatment Market, by Route of Administration
10.1.2.3 North America: Malaria Treatment Market, by Distribution Channel
10.1.2.3.1 North America: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.3.2 North America: Malaria Treatment Market, by Retail Pharmacies
10.1.2.4 North America: Malaria Treatment Market, by Country
10.1.2.5 US
10.1.2.6 Overview
10.1.2.6.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.2 US: Malaria Treatment Market, by Treatment
10.1.2.6.3 US: Malaria -Malaria Treatment Market, by Route of Administration
10.1.2.6.4 US: Malaria Treatment Market, by Distribution Channel
10.1.2.6.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.6.4.2 US: Malaria Treatment Market, by Retail Pharmacies
10.1.2.7 Canada
10.1.2.8 Overview
10.1.2.8.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.2 Canada: Malaria Treatment Market, by Treatment
10.1.2.8.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
10.1.2.8.4 Canada: Malaria Treatment Market, by Distribution Channel
10.1.2.8.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.8.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
10.1.2.9 Mexico
10.1.2.10 Overview
10.1.2.10.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.2 Mexico: Malaria Treatment Market, by Treatment
10.1.2.10.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
10.1.2.10.4 Mexico: Malaria Treatment Market, by Distribution Channel
10.1.2.10.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.10.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10.2 Europe Malaria Treatment Market, Revenue and Forecast To 2030
10.2.1 Overview
10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.1 Europe: Malaria Treatment Market, by Treatment
10.2.2.2 Europe: Malaria Treatment Market, by Route of Administration
10.2.2.3 Europe: Malaria Treatment Market, by Distribution Channel
10.2.2.3.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.3.2 Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.2.4 Europe: Malaria Treatment Market, by Countries
10.2.2.5 France
10.2.2.6 Overview
10.2.2.6.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.6.2 France: Malaria Treatment Market, by Treatment
10.2.2.6.3 France: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.6.4 France: Malaria Treatment Market, by Distribution Channel
10.2.2.6.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.6.4.2 France: Malaria Treatment Market, by Retail Pharmacies
10.2.2.7 UK
10.2.2.8 Overview
10.2.2.8.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.8.2 UK: Malaria Treatment Market, by Treatment
10.2.2.8.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.8.4 UK: Malaria Treatment Market, by Distribution Channel
10.2.2.8.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.8.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
10.2.2.9 Italy
10.2.2.10 Overview
10.2.2.10.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.10.2 Italy: Malaria Treatment Market, by Treatment
10.2.2.10.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.10.4 Italy: Malaria Treatment Market, by Distribution Channel
10.2.2.10.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.10.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
10.2.2.11 Germany
10.2.2.12 Overview
10.2.2.12.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.12.2 Germany: Malaria Treatment Market, by Treatment
10.2.2.12.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.12.4 Germany: Malaria Treatment Market, by Distribution Channel
10.2.2.12.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.12.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
10.2.2.13 Spain
10.2.2.14 Overview
10.2.2.14.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.14.2 Spain: Malaria Treatment Market, by Treatment
10.2.2.14.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.14.4 Spain: Malaria Treatment Market, by Distribution Channel
10.2.2.14.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.14.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
10.2.2.15 Rest of Europe
10.2.2.16 Overview
10.2.2.16.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.16.2 Rest of Europe: Malaria Treatment Market, by Treatment
10.2.2.16.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.16.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
10.2.2.16.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.16.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10.3 Asia Pacific Malaria Treatment Market, Revenue and Forecast To 2030
10.3.1 Overview
10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.1 Asia Pacific: Malaria Treatment Market, by Treatment
10.3.2.2 Asia Pacific: Malaria Treatment Market, by Route of Administration
10.3.2.3 Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.2.3.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.3.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.2.4 Asia Pacific: Malaria Treatment Market, by Countries
10.3.2.5 Japan
10.3.2.6 Overview
10.3.2.6.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.6.2 Japan: Malaria Treatment Market, by Treatment
10.3.2.6.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.6.4 Japan: Malaria Treatment Market, by Distribution Channel
10.3.2.6.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.6.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
10.3.2.7 India
10.3.2.8 Overview
10.3.2.8.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.8.2 India: Malaria Treatment Market, by Treatment
10.3.2.8.3 India: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.8.4 India: Malaria Treatment Market, by Distribution Channel
10.3.2.8.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.8.4.2 India: Malaria Treatment Market, by Retail Pharmacies
10.3.2.9 South Korea
10.3.2.10 Overview
10.3.2.10.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.10.2 South Korea: Malaria Treatment Market, by Treatment
10.3.2.10.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.10.4 South Korea: Malaria Treatment Market, by Distribution Channel
10.3.2.10.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.10.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
10.3.2.11 Australia
10.3.2.12 Overview
10.3.2.12.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.12.2 Australia: Malaria Treatment Market, by Treatment
10.3.2.12.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.12.4 Australia: Malaria Treatment Market, by Distribution Channel
10.3.2.12.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.12.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
10.3.2.13 Rest of Asia Pacific
10.3.2.14 Overview
10.3.2.14.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.14.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
10.3.2.14.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.14.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.2.14.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.14.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.4 Middle East & Africa Malaria Treatment Market, Revenue and Forecast To 2030
10.4.1 Overview
10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.1 Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.2.2 Middle East & Africa: Malaria Treatment Market, by Route of Administration
10.4.2.3 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.2.3.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.3.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.2.4 Middle East & Africa: Malaria Treatment Market, by Country
10.4.2.5 Saudi Arabia
10.4.2.6 Overview
10.4.2.6.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.6.2 Saudi Arabia: Malaria Treatment Market, by Treatment
10.4.2.6.3 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.6.4 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
10.4.2.6.4.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.6.4.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
10.4.2.7 UAE
10.4.2.8 Overview
10.4.2.8.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.8.2 UAE: Malaria Treatment Market, by Treatment
10.4.2.8.3 UAE: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.8.4 UAE: Malaria Treatment Market, by Distribution Channel
10.4.2.8.4.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.8.4.2 UAE: Malaria Treatment Market, by Retail Pharmacies
10.4.2.9 South Africa
10.4.2.10 Overview
10.4.2.10.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.10.2 South Africa: Malaria Treatment Market, by Treatment
10.4.2.10.3 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.10.4 South Africa: Malaria Treatment Market, by Distribution Channel
10.4.2.10.4.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.10.4.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.2.11 Kenya
10.4.2.12 Overview
10.4.2.12.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.12.2 Kenya: Malaria Treatment Market, by Treatment
10.4.2.12.3 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.12.4 Kenya: Malaria Treatment Market, by Distribution Channel
10.4.2.12.4.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.12.4.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
10.4.2.13 Tanzania
10.4.2.14 Overview
10.4.2.14.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.14.2 Tanzania: Malaria Treatment Market, by Treatment
10.4.2.14.3 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.14.4 Tanzania: Malaria Treatment Market, by Distribution Channel
10.4.2.14.4.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.14.4.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
10.4.2.15 Rwanda
10.4.2.16 Overview
10.4.2.16.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.16.2 Rwanda: Malaria Treatment Market, by Treatment
10.4.2.16.3 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.16.4 Rwanda: Malaria Treatment Market, by Distribution Channel
10.4.2.16.4.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.16.4.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
10.4.2.17 Nigeria
10.4.2.18 Overview
10.4.2.18.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.18.2 Nigeria: Malaria Treatment Market, by Treatment
10.4.2.18.3 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.18.4 Nigeria: Malaria Treatment Market, by Distribution Channel
10.4.2.18.4.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.18.4.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
10.4.2.19 Ghana
10.4.2.20 Overview
10.4.2.20.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.20.2 Ghana: Malaria Treatment Market, by Treatment
10.4.2.20.3 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.20.4 Ghana: Malaria Treatment Market, by Distribution Channel
10.4.2.20.4.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.20.4.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
10.4.2.21 Uganda
10.4.2.22 Overview
10.4.2.22.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.22.2 Uganda: Malaria Treatment Market, by Treatment
10.4.2.22.3 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.22.4 Uganda: Malaria Treatment Market, by Distribution Channel
10.4.2.22.4.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.22.4.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
10.4.2.23 Angola
10.4.2.24 Overview
10.4.2.24.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.24.2 Angola: Malaria Treatment Market, by Treatment
10.4.2.24.3 Angola: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.24.4 Angola: Malaria Treatment Market, by Distribution Channel
10.4.2.24.4.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.24.4.2 Angola: Malaria Treatment Market, by Retail Pharmacies
10.4.2.25 Cameroon
10.4.2.26 Overview
10.4.2.26.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.26.2 Cameroon: Malaria Treatment Market, by Treatment
10.4.2.26.3 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.26.4 Cameroon: Malaria Treatment Market, by Distribution Channel
10.4.2.26.4.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.26.4.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
10.4.2.27 Senegal
10.4.2.28 Overview
10.4.2.28.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.28.2 Senegal: Malaria Treatment Market, by Treatment
10.4.2.28.3 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.28.4 Senegal: Malaria Treatment Market, by Distribution Channel
10.4.2.28.4.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.28.4.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
10.4.2.29 Zambia
10.4.2.30 Overview
10.4.2.30.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.30.2 Zambia: Malaria Treatment Market, by Treatment
10.4.2.30.3 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.30.4 Zambia: Malaria Treatment Market, by Distribution Channel
10.4.2.30.4.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.30.4.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
10.4.2.31 Rest of Middle East & Africa
10.4.2.32 Overview
10.4.2.32.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.32.2 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.2.32.3 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.32.4 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.2.32.4.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.32.4.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.5 South & Central America Malaria Treatment Market, Revenue and Forecast To 2030
10.5.1 Overview
10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.1 South & Central America: Malaria Treatment Market, by Treatment
10.5.2.2 South & Central America: Malaria Treatment Market, by Route of Administration
10.5.2.3 South & Central America: Malaria Treatment Market, by Distribution Channel
10.5.2.3.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
10.5.2.3.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
10.5.2.4 South & Central America: Malaria Treatment Market, by Countries
10.5.2.5 Brazil
10.5.2.6 Overview
10.5.2.6.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.6.2 Brazil: Malaria Treatment Market, by Treatment
10.5.2.6.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
10.5.2.6.4 Brazil: Malaria Treatment Market, by Distribution Channel
10.5.2.6.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
10.5.2.6.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
10.5.2.7 Argentina
10.5.2.8 Overview
10.5.2.9 Rest of South & Central America
10.5.2.10 Overview
10.5.2.10.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.10.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
10.5.2.10.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
10.5.2.10.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
10.5.2.10.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
10.5.2.10.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies
11. Malaria Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Malaria Treatment Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Cipla Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sun Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sanofi SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GSK Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pfizer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Service
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AdvaCare Pharma USA LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 VLP Therapeutics LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Lupin Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
14. Appendix
List of Tables
Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 5. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 6. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 7. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 8. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 9. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 10. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 11. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 12. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 13. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 14. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 15. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 16. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 17. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 18. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 19. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 20. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 21. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 23. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 24. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 25. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 26. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 27. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 28. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 29. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 30. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 31. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 32. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 33. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 34. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 35. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 36. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 37. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 38. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 39. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 40. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 41. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 42. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 43. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 44. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 45. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 46. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 47. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 48. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 49. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 50. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 51. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 52. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 53. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 54. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 55. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 56. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 57. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 58. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 60. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 61. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 62. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 63. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 64. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 65. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 66. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 67. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 69. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 71. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 72. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 73. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 74. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 75. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 76. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 77. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 78. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 79. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 80. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 81. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 82. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 83. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 84. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 85. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 86. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 87. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 88. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 89. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 90. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 91. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 92. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 93. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 94. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 95. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 96. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 97. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 98. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 99. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 100. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 101. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 102. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 103. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 104. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 105. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 106. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 107. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 108. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 109. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 110. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 111. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 112. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 113. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 114. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 115. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 116. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 117. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 118. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 119. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 120. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 121. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 122. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 123. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 124. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 125. Nigeria Malaria Treatment Market, by Treatment – Revenue and Forecast to 2030 (USD Million)
Table 126. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 127. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 128. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 129. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 130. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 131. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 132. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 133. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 134. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 135. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 136. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 137. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 138. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 139. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 140. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 141. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 142. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 143. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 144. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 145. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 146. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 147. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 148. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 149. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 150. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 151. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 152. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 153. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 154. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 155. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 156. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 157. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 158. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 159. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 160. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 161. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 162. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 163. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 164. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 165. South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 166. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 167. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 168. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 169. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 170. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 171. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 172. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 173. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 174. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 175. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 176. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 177. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 178. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 179. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 180. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 181. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 182. Glossary of Terms, Malaria Treatment Market
List of Figures
Figure 1. PEST Analysis - Malaria
Figure 2. Malaria Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Malaria Treatment Market Revenue (US$ million), 2020 – 2030
Figure 5. Malaria: Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 6. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 7. Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 8. Generic Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 9. Originators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 10. Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 12. Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 15. Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hospital Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 21. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 23. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 27. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 29. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Malaria Treatment Market, 2022 ($Mn)
Figure 36. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 38. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Malaria Treatment Market, 2022 (US$ Mn)
Figure 44. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 46. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Malaria Treatment Market, 2022 ($Mn)
Figure 61. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 62. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 63. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 65. Growth Strategies in the Malaria Treatment Market
The List of Companies - Malaria Treatment Market
- Cipla Ltd
- Pfizer Inc
- Sun Pharmaceutical Industries Ltd
- Sanofi SA.
- GSK Plc
- Novartis AG
- Pfizer Inc
- AdvaCare Pharma USA LLC
- VLP Therapeutics LLC
- Lupin Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For